2017
DOI: 10.1253/circj.cj-16-0945
|View full text |Cite
|
Sign up to set email alerts
|

Eccentric Left Ventricular Hypertrophy in Aortic Stenosis Caused by Unicuspid Aortic Valve

Abstract: decrescendo systolic murmur was heard at the second right intercostal space. Electrocardiogram showed left ventricular (LV) hypertrophy with normal QRS complexes. On transthoracic echocardiography the LV ejection fraction (LVEF)A 46-year-old man was referred to Ehime University Hospital for the treatment of refractory heart failure. On admission, blood pressure was 98/68 mmHg and heart rate was 92 beats/minute. A harsh crescendo- IMAGES IN CARDIOVASCULAR MEDICINE

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

1
2
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
4

Relationship

1
3

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 4 publications
1
2
0
Order By: Relevance
“…We appreciate Dr. Morita's and Dr. Komuro's interest in our study. 1 We concur with their comments. As stated by Dr. Morita, family history information is mandatory when caring for patients with dilated cardiomyopathy, whether familial or not.…”
supporting
confidence: 58%
“…We appreciate Dr. Morita's and Dr. Komuro's interest in our study. 1 We concur with their comments. As stated by Dr. Morita, family history information is mandatory when caring for patients with dilated cardiomyopathy, whether familial or not.…”
supporting
confidence: 58%
“…1 The patient in this case suffered from refractory heart failure with enlarged LV end-diastolic diameter of 65 mm and reduced LV ejection fraction of 33%. It would be natural for the authors to consider the co-existence of "idiopathic" dilated cardiomyopathy (DCM) in this case, because the aortic stenosis caused by the unicuspid aortic valve could not explain well this obvious LV dilatation.…”
Section: To the Editormentioning
confidence: 90%
“…In adult population, the most common treatment modality is aortic valve replacement (AVR). Many require AVR in middle age, on average, in their third decade of life [2, 67]. In UAV, AVR is about 10–20 years earlier than BAV and 20–30 years earlier than TAV [5, 14, 16].…”
Section: Therapeutic Approachesmentioning
confidence: 99%